SF1499

Limitations modification on optometrists prescribing and administering drugs
Legislative Session 94 (2025-2026)

Related bill: HF3195

AI Generated Summary

This legislative bill, S.F. No. 1499, is a proposal to amend an existing law in Minnesota that governs the practice of optometry. The amendment specifically focuses on expanding the authority of optometrists in prescribing and administering certain types of drugs.

The bill defines the scope of optometry and lists the activities considered as practicing optometry, such as diagnosing eye-related diseases, prescribing lenses, and using specific testing devices for vision. The significant change proposed by the bill involves the conditions under which optometrists can prescribe or administer "legend drugs," which are drugs that legally require a prescription.

Under the proposed amendment, optometrists would still be prohibited from performing certain actions, like administering drugs intravenously or engaging in invasive surgery. Additionally, it sets specific limits on prescribing and administering certain classes of drugs, such as limiting the use of oral antivirals to no more than ten days and oral steroids to no more than fourteen days without consulting a physician.

In simpler terms, the bill aims to modify existing laws to allow optometrists to have broader but controlled prescription rights for specific medications, enhancing their ability to treat and manage eye-related conditions while still maintaining certain restrictions for safety.

Bill text versions

Showing the most recent version. There are  3  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
February 17, 2025SenateActionIntroduction and first reading
February 17, 2025SenateActionReferred toHealth and Human Services
February 27, 2025SenateActionAuthor added
March 27, 2025SenateActionAuthor stricken
SenateActionSee
Showing the 5  most recent stages. This bill has 5  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…